[gnso-gac-closed-generics] Outline of next steps and proposed agenda for Tuesday session at ICANN77

Jeff Neuman jeff at jjnsolutions.com
Mon Jun 12 22:05:02 UTC 2023 

I agree 100%.  I know many of them will not have read the framework, so lets post parts up on the screen and open the floor.

Get Outlook for iOS<https://aka.ms/o0ukef>
________________________________
From: Sophie Hey <sophie.hey at comlaude.com>
Sent: Monday, June 12, 2023 5:02 PM
To: Manal Ismail <manal at tra.gov.eg>; Jeff Neuman <jeff at jjnsolutions.com>; Mary Wong <mary.wong at icann.org>; gnso-gac-closed-generics at icann.org <gnso-gac-closed-generics at icann.org>
Subject: RE: Outline of next steps and proposed agenda for Tuesday session at ICANN77

I support Manal's suggestion

Sophie Hey
Policy Advisor

+44 (0) 20 7421 8250
252

comlaude.com
-----Original Message-----
From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> On Behalf Of Manal Ismail
Sent: Monday, June 12, 2023 4:59 PM
To: Jeff Neuman <jeff at jjnsolutions.com>; Mary Wong <mary.wong at icann.org>; gnso-gac-closed-generics at icann.org
Subject: Re: [gnso-gac-closed-generics] Outline of next steps and proposed agenda for Tuesday session at ICANN77

Many thanks Patricio for the good suggestion and Melissa and Mary for accomodating ..


If group participants agree, I suggest that we reverse the order of the comments, and do not have to necessarily divide the time equally .. We have already spoken for the whole session today, and I would like to see us favoring community input during this session .. That said, in order to secure enough time for community feedback during this session​, I propose we start each block by listening to community interventions, then respond or comment as apporiate ..


Thoughts?


Kind Regards

--Manal


________________________________
From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> on behalf of Jeff Neuman <jeff at jjnsolutions.com>
Sent: Monday, June 12, 2023 10:06 PM
To: Mary Wong; gnso-gac-closed-generics at icann.org
Subject: Re: [gnso-gac-closed-generics] Outline of next steps and proposed agenda for Tuesday session at ICANN77

Mary,

I guess I agree on agenda. The rest of the email on what happens next is beyond scope of group.

Get Outlook for iOS<https://aka.ms/o0ukef>
________________________________
From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> on behalf of Mary Wong <mary.wong at icann.org>
Sent: Monday, June 12, 2023 2:02:48 PM
To: gnso-gac-closed-generics at icann.org <gnso-gac-closed-generics at icann.org>
Subject: [gnso-gac-closed-generics] Outline of next steps and proposed agenda for Tuesday session at ICANN77


Dear all,



Based on the questions and discussions at the first open session held earlier today, and to prepare for the second open session coming up tomorrow, staff would like to outline what we understand to be the next steps for the dialogue work leading up to a Final Framework. We have started to document next steps on your public wiki space<https://community.icann.org/display/GFDOCG/FOR+INPUT%3A+Draft+Framework+for+Closed+Generic+gTLDs>, and we plan on including this information in the twice-weekly Community Leadership Digest that the Policy Development Support team publishes for the community, up to the suggested closing date of 15 July 2023. We will also coordinate with our colleagues that support all the different SOAC groups, to ensure that their members are aware of the invitation to provide feedback on the Draft Framework.



We have set up an email address where community groups and individuals can send in their input directly: closed-generics-feedback at icann.org<mailto:closed-generics-feedback at icann.org>. This is a publicly-archived<https://mm.icann.org/pipermail/closed-generics-feedback/> mailing list, which means that you and anyone that wishes to can see the submissions as they come in, in full. The staff team will ensure that all submissions are made public via the wiki and, similar to the support we provide to other community policy-related efforts, collate the feedback into a single tool to facilitate your discussions on the input received.



In addition, and to encourage community groups to submit input, they may send their feedback through their staff support team.



As these steps mirror those that we follow for more formal Public Comment proceedings, we hope that this approach, which also ensures that all feedback is documented and made public, addresses any concerns from community members about transparency, accessibility and their ability to provide feedback on the Draft Framework.



After your deliberations on a Final Framework following your review of the community input, our understanding is that the three groups that are participating in the dialogue (i.e. the ALAC, GAC and GNSO Council) will each use their own internal processes to signal whether they agree with the proposed approach in the Final Framework. This is expected to take place in the third quarter of this calendar year, and will be the final step before moving ahead with the requisite policy work through a GNSO Council-chartered process in which the ALAC and GAC will also be involved. Of course, as noted in the Draft Framework, if the group does not reach agreement on a Final Framework, the issue of closed generic gTLDs will revert to the ICANN Board for a decision on the matter for the next round.



Finally, please find below the proposed agenda for the open session tomorrow:



  1.  Review of the Draft Framework - Melissa Peters Allgood & Dialogue Participants (80 mins)

(i)                  Application  (30 mins)

                                Participant comments  (15 mins)

                                Community Q&A  (15 mins)

(ii)                Evaluation  (30 mins)

                                Participant comments  (15 mins)

                                Community Q&A  (15 mins)

(iii)               Contracting & Post-Delegation  (20 mins)

                                Participant comments  (10 mins)

Community Q&A  (10 mins)



  1.  Next Steps - Melissa Peters Allgood (5 mins)



Best regards,



Mary (on behalf of Melissa Peters Allgood and the staff team supporting the facilitated dialogue) _______________________________________________
gnso-gac-closed-generics mailing list
gnso-gac-closed-generics at icann.org
https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics

_______________________________________________
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and the website Terms of Service (https://www.icann.org/privacy/tos). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.
________________________________
 The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that Com Laude Group Limited (the “Com Laude Group”) does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group is a limited company registered in England and Wales with company number 10689074 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 6181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176 and registered office at 15 William Street, South West Lane, Edinburgh, EH3 7LL Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, a corporation incorporated in the State of Washington and principal office address at Suite 332, Securities Building, 1904 Third Ave, Seattle, WA 98101; Com Laude (Japan) Corporation, a company registered in Japan with company number 0100-01-190853 and registered office at 1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a company registered in Spain and registered office address at Calle Barcas 2, 2, Valencia, 46002, Spain. For further information see http://www.comlaude.com/<https://comlaude.com/>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230612/f7c74de2/attachment-0001.html>

More information about the gnso-gac-closed-generics mailing list